Literature DB >> 29408813

GTPBP4 Promotes Gastric Cancer Progression via Regulating P53 Activity.

Li Li1, Xunlei Pang1, Zuan Zhu1, Lili Lu1, Jun Yang1, Jiang Cao2, Sujuan Fei1.   

Abstract

BACKGROUND/AIMS: gastric cancer is a serious health concern with high morbidity and mortality. Therefore, it is urgent to find novel targets for gastric cancer diagnosis and treatment.
METHODS: qRT-PCR and immunohistochemistry assays were used to detect GTPBP4 expression in gastric cancer tissues, and gastric cancer and gastric epithelial cells. Lentivirus infection was used to construct GTPBP4 stable knockdown cells. Annexin V/PI apoptosis, CCK8, EdU incorporation and cell clone formation analysis were performed to evaluate the effects of GTPBP4 on gastric cancer cell proliferation and apoptosis. Further RNA-based high-throughput sequencing and co-IP assays were constructed to explore the related mechanisms contributing to GTPBP4-mediated effects.
RESULTS: GTPBP4 expression was significantly increased in gastric cancer tissues compared with that in adjacent normal tissues, and positively correlated with gastric cancer stages. Meanwhile, GTPBP4 level was markedly upregulated in gastric cancer cells than in gastric epithelial cells. Additionaly, stable knockdown of GTPBP4 inhibited cell proliferation and promoted cell apoptosis. Mechanistically, p53 and its related signaling were significantly activated in GTPBP4 stable knockdown cells. And GTPBP4 interacted with p53 in gastric cancer cells.
CONCLUSIONS: our results provide insights into mechanistic regulation and linkage of the GTPBP4-p53 in gastric cancer, and also a valuable potential target for gastric cancer.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  AGS; Gtpbp4; MKN-45; gastric cancer; p53

Mesh:

Substances:

Year:  2018        PMID: 29408813     DOI: 10.1159/000487160

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer.

Authors:  Yiming Hu; Jiaheng Xie; Liang Chen; Qikai Tang; Wei Wei; Wenfeng Lin; Wang Du; Tinghong Xiang; Lu Yin; Jing Ji
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

2.  A translation control module coordinates germline stem cell differentiation with ribosome biogenesis during Drosophila oogenesis.

Authors:  Elliot T Martin; Patrick Blatt; Elaine Nguyen; Roni Lahr; Sangeetha Selvam; Hyun Ah M Yoon; Tyler Pocchiari; Shamsi Emtenani; Daria E Siekhaus; Andrea Berman; Gabriele Fuchs; Prashanth Rangan
Journal:  Dev Cell       Date:  2022-04-11       Impact factor: 13.417

3.  Identification and Functional Analyses of Host Proteins Interacting with the p17 Protein of Avian Reovirus.

Authors:  Chengcheng Zhang; Xinyi Liu; Fuxi Zhao; Qingqing Zhang; Wei Zuo; Mengjiao Guo; Xiaorong Zhang; Yantao Wu
Journal:  Viruses       Date:  2022-04-25       Impact factor: 5.818

4.  Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.

Authors:  Zhiqian Zhang; Juan Wang; Jiayan Mao; Fangqiong Li; Wei Chen; Wei Wang
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

5.  LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.

Authors:  Nuobei Zhang; Hao Shen; Shenan Huang; Fenfen Wang; Huifang Liu; Fen Xie; Lei Jiang; Xin Chen
Journal:  Eur J Histochem       Date:  2021-11-16       Impact factor: 3.188

6.  Zinc Finger Protein 521, Negatively Regulated by MicroRNA-204-5p, Promotes Proliferation, Motility and Invasion of Gastric Cancer Cells.

Authors:  Chen Huan; Cai Xiaoxu; Ren Xifang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

7.  A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma.

Authors:  Yuanfang Sun; Shasha Li; Jin Li; Xue Xiao; Zhaolai Hua; Xi Wang; Shikai Yan
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.